Thursday, October 2, 2014

Art Sample Of Duck To Put On Boards


Tuesday, September 16, 2014

Fwd: Weighing Surgical Options for Breast Cancer


---------- Forwarded message ----------
From: National Institutes of Health (NIH) <nih.ocpl@service.govdelivery.com>
Date: Tue, Sep 16, 2014 at 6:40 AM
Subject: Weighing Surgical Options for Breast Cancer
To: iammejtm@gmail.com


Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to NIH Director's Blog for National Institutes of Health (NIH).

A group of women, standing together, holding hands

 

09/16/2014 09:00 AM EDT

An increasing number of women with cancer in one breast are choosing to have both breasts surgically removed in hopes of reducing the chance of developing cancer in the unaffected breast. But does this approach—called bilateral, or double, mastectomy—really improve the odds of survival? A new NIH-funded study indicates that, for the vast majority of […]

 


Update Your E-mail Address | Add Subscriptions | Unsubscribe

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact NIHinfo@od.nih.gov. Before writing, please view our Frequently Asked Questions page, our A-Z Health Topics page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIH…Turning Discovery Into Health® 


This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612 Powered by GovDelivery



--
Jeremy Tobias Matthews

Fwd: Kids.gov October Calendar


---------- Forwarded message ----------
From: Kids.gov Update <kids.gov@subscriptions.usa.gov>
Date: Tue, Sep 16, 2014 at 6:44 AM
Subject: Kids.gov October Calendar
To: iammejtm@gmail.com


 

Kids.gov October Calendar

 

October is just around the corner and we are featuring lots of resources in our October calendar. Kids can learn about energy during Energy Action Month. Teach them how to stay safe online during National Cybersecurity Awareness Month. During October, we also celebrate our planet and learn ways to conserve and protect it during Earth Science Week. Last, but not least, we have resources for parents and kids on how to keep safe when trick or treating on Halloween. Check out our Kids.gov calendar to see what else is in store for the month of October.

 

 

Bookmark and Share


Subscriber Services:
Manage Preferences | Unsubscribe | Help

Kids.gov: A Safe Place to Learn and Play
If you have questions, contact us.

Watch Us   Follow Us  Like Us  Pin Us


This email was sent to iammejtm@gmail.com from: Kids.gov · General Services Administration · OCSIT · 1800 F Street NW · Washington, DC 20405 · (800) 333-4636



--
Jeremy Tobias Matthews

Fwd: CDER New September 16, 2014


---------- Forwarded message ----------
From: U.S. Food & Drug Administration (FDA) <fda@service.govdelivery.com>
Date: Tue, Sep 16, 2014 at 7:17 AM
Subject: CDER New September 16, 2014
To: iammejtm@gmail.com


FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

September 15, 2014


New and Generic Drug Approvals

September 12, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Advil Liqui-Gels ibuprofen Capsule;Oral Pfizer Manufacturing Change or Addition
Advil Migraine Liqui-Gels ibuprofen Capsule;Oral Pfizer Manufacturing Change or Addition
Afinitor everolimus Tablet;Oral Novartis Manufacturing Change or Addition
Allegra Allergy fexofenadine hydrochloride Tablet;Oral Sanofi Aventis Us Labeling Revision
Allegra Hives fexofenadine hydrochloride Tablet;Oral Sanofi Aventis Us Labeling Revision
Amlodipine and Valsartan amlodipine;valsartan Tablet;Oral Torrent Pharms Ltd Tentative Approval
An-Sulfur Colloid technetium tc-99m sulfur colloid kit Solution;Injection, Oral Pharmalucence Manufacturing Change or Addition
Children's Allegra Allergy fexofenadine hydrochloride Tablet;Oral Sanofi Aventis Us Labeling Revision
Children's Allegra Hives fexofenadine hydrochloride Tablet;Oral Sanofi Aventis Us Labeling Revision
Clindamycin Phosphate and Benzoyl Peroxide benzoyl peroxide; clindamycin phosphate Gel;Topical Mylan Pharms Inc Manufacturing Change or Addition
Daptomycin daptomycin Injectable;Injection Hospira Inc Approval
Emtricitabine;Tenofovir Disoproxil Fumarate;Nevirapine emtricitabine;tenofovir disoproxil fumarate;nevirapine Tablet;Oral Mylan Labs Ltd Tentative Approval
Forteo teriparatide recombinant human Injectable;Subcutaneous Lilly Manufacturing Change or Addition
Glycine 1.5% In Plastic Container glycine Solution;Irrigation B Braun Manufacturing Change or Addition
Humalog insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humalog Kwikpen insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humalog Mix 50/50 insulin lispro protamine recombinant; insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humalog Mix 50/50 Kwikpen insulin lispro protamine recombinant; insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humalog Mix 50/50 Pen insulin lispro protamine recombinant; insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humalog Mix 75/25 insulin lispro protamine recombinant; insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humalog Mix 75/25 Kwikpen insulin lispro protamine recombinant; insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humalog Mix 75/25 Pen insulin lispro protamine recombinant; insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humalog Pen insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humatrope somatropin recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humulin 70/30 insulin recombinant human; insulin susp isophane recombinant human Injectable;Injection Lilly Manufacturing Change or Addition
Humulin 70/30 Pen insulin recombinant human; insulin susp isophane recombinant human Injectable;Injection Lilly Manufacturing Change or Addition
Humulin N insulin susp isophane recombinant human Injectable;Injection Lilly Manufacturing Change or Addition
Mycophenolate Mofetil mycophenolate mofetil Capsule;Oral Roxane Manufacturing Change or Addition
Mycophenolate Mofetil mycophenolate mofetil Tablet;Oral Roxane Manufacturing Change or Addition
Naprelan naproxen sodium Tablet, Extended Release;Oral Almatica Pharma Inc Manufacturing Change or Addition
Pomalyst pomalidomide Capsule;Oral Celgene Labeling Revision
Revlimid lenalidomide Capsule;Oral Celgene Labeling Revision
Thalomid thalidomide Capsule;Oral Celgene Supplement
Vibra-Tabs doxycycline hyclate Tablet;Oral Pfizer Labeling Revision
Vibramycin doxycycline For Suspension;Oral Pfizer Labeling Revision
Vibramycin doxycycline hyclate Capsule;Oral Pfizer Labeling Revision
Vibramycin doxycycline calcium Suspension;Oral Pfizer Labeling Revision
Zoloft sertraline hydrochloride Tablet;Oral Pfizer Labeling Revision
Zoloft sertraline hydrochloride Concentrate;Oral Pfizer Labeling Revision

 


FDA Logo

Subscriber Services:
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:
Visit Us on Facebook Visit Us on Twitter Visit Us on YouTube Sign up for email updates Visit Us on Flickr Visit Our Blog  

This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery



--
Jeremy Tobias Matthews

Fwd: The Five Hottest Innovation Tools


---------- Forwarded message ----------
From: National Institute of Standards and Technology (NIST) <subscriptions@nist.gov>
Date: Tue, Sep 16, 2014 at 7:52 AM
Subject: The Five Hottest Innovation Tools
To: iammejtm@gmail.com


You are subscribed to Manufacturing Innovations Blog for National Institute of Standards and Technology (NIST).

This information has recently been updated, and is now available.

09/15/2014 08:50 PM EDT

This article originally appeared in the InnnovationTrends monthly newsletter. Guest blog post by Robert Tucker, president of The Innovation Resource Consulting Group, and the author of seven books on innovation. In 25 years in the innovation field, I've seen a lot of innovation tools come and go. Let's face it, tools are trendy. They get

The post The Five Hottest Innovation Tools appeared first on Manufacturing Innovation Blog.


NIST Logo Questions? Contact Us

STAY CONNECTED:
Visit Us on Facebook Visit Us on Twitter Visit Us on YouTube Sign up for email updates

SUBSCRIBER SERVICES:
Manage Preferences  |  Unsubscribe  |  Help

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com.
Technical questions? Contact inquiries@nist.gov. (301) 975-NIST (6478).

This service is provided to you at no charge by National Institute of Standards and Technology (NIST). 100 Bureau Drive, Stop 1070 · Gaithersburg, MD 20899 · 301-975-6478

Powered by GovDelivery



--
Jeremy Tobias Matthews